{'fraction_non_alphanumeric': 0.017475728155339806, 'fraction_numerical': 0.005825242718446602, 'mean_word_length': 5.2926829268292686, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The hepatitis B carrier state.

Acute hepatitis B virus infection resolves in 95 percent of patients within one year. The remaining 5 percent have persistent infection and become chronic carriers. In the United States, there are nearly one million carriers, who are at increased risk of developing immune-complex disorders and liver diseases. Treatment is available to reduce vertical transmission, and ongoing trials of immunosuppressive and antiviral agents are aimed at decreasing or resolving viral replication.